Pathological cardiac hypertrophy is manifested by alterations in cardiac contractile proteins [α-skeletal actin and the α- to β- myosin heavy chain (MHC) switch], increased expression of fetal genes such as atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP). Here, NPPA is linked to cardiac hypertrophy.